Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1283-1286

  Yeh, Kun Huei ^a,b   Chen, Yao Chang ^a,b   Yeh, Shiou Hwei ^b   Chen, Chun Ping ^b   Lin, Jaw Town ^a   Cheng, Ann Lii ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Circulating cancer cells; Cytokeratin 19; Gastric cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 19; DNA FRAGMENT; MESSENGER RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; INTERMEDIATE FILAMENT; MALE; MESSENGER RNA SYNTHESIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ADULT; AGED; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; STOMACH NEOPLASMS;

EID: 0031830576     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles TJ, and Coombes RC: Micrometastasis in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastasis. Br Med J 295: 1093-1096, 1987.
2. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, and Bastert G: Detection of tumor cells in the bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10: 1534-1539, 1992.
3. Schlimok G, Funke 1, Bock B, Schweiberer B, Witte J, and Riethmuller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8: 831-837, 1990.
4. Schlimok G, Funke 1, Pantel K, Strobel F, Lindemann F, Witte J, and Reithmuller G: Micrometastatic tumor cells in bone marow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27: 1461-1465, 1991.
5. Bartek J, Bartkova J, Schneider J, Taylor-Papadimitriou J, Kovarik J, and Rejthar A: Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumors and culture cells. Eur J Cancer Clin Oncol 22: 1441-1452, 1986.
6. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ, and Osborne MP: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12: 333-340, 1988.
7. Broers JL, Ramaekers FCS, Rot MK, Oostendorp T, Huysmans A, van Muijen GN, Wagenaar SS, and Vooijs GP: Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 48: 3221-3229, 1988.
8. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, and Sweet D: Detection and viability of tumor cells in the peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82: 2605-2610, 1993.
9. Litle VR, Warren RS, Moore D, and Pallavicini MG: Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer 79: 1664-1670, 1997.
10. Mattano LA, Moss TJ, and Enerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-4705, 1992.
11. Smith B, Selby P, Southgate J, Pittman K, Bradley C, and Blair GE: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229, 1991.
12. Yeh KH, Lin MT, Tang JL, Yang CH, Tsay W, and Chen YC. Long-term disease-free survival after autologous bone marrow transplantation in a primary plasma cell leukemia: detection of minimal residual disease in the transplant marrow by third-complementarity-determining region-specific probes. Br J Haematol 89: 914-916, 1995.
13. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, and Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482, 1994.
14. Yeh KH, Yeh SH, Lin MT, Hong RL, Lin DT, Lin JF, Shen TS, Cheng AL, Hsu MM, and Chen YC: Cytokeratin-19 (K19) gene expression in metastatic nasopharyngeal carcinoma: detection by nested reverse-transcriptase polymerase chain reaction. Proc Am Assoc Cancer Res 37: 79 (abstract 549), 1996.
15. Moll R, Franke WW, Schiller DL, Geiger B, and Krepler R: The catalog of human cytokeratins: pattern of expression in normal epithelia, tumor and cultured cells. Cell 31: 11-24, 1982.
16. Cheng AL, Yeh KH, Chen YC, Lin JT, Chen BR, Liu MY, Lin MT, Lee WJ, Lee PH, Wang CH, and Wang TH: PE-HDFL: an effective combination chemotherapy for advanced gastric cancers. Proc Am Soc Clin Oncol 15: 495 (abstract 1582), 1996.
17. Hsu CH, Yeh KH, Chen LT, Liu JM, Jan CM, Lin JT, Chen YC, and Cheng AL: Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers: an effective and low-toxic regimen for patients with poor general condition. Oncology 54: 275-280, 1997.
18. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol 64: 31-49, 1965.
19. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, and van de Velde CJ: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441-1447, 1993.